← back to search

Kathryn A. Phillips

University of California, San Francisco · US
Area of research
Economics and Econometrics · Genetics
Research interest
Research interests include Health Systems, Economic Evaluations, Quality of Life, BRCA gene mutations in cancer, Genomics and Rare Diseases, and Cancer Genomics and Diagnostics.
h-index
42
citations
7,317
works
205
NIH funding
primary concept
email

Recent publications

Perspectives of private payers on multicancer early-detection tests: informing research, implementation, and policy
Health Affairs Scholar 2023cited by 14position: lastdoi
Availability and funding of clinical genomic sequencing globally
BMJ Global Health 2021cited by 92position: firstdoi
Complicated legacies: The human genome at 20
Science 2021cited by 43position: middledoi
US private payers’ perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER)
Genetics in Medicine 2021cited by 27position: firstdoi
Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling
Value in Health 2020cited by 54position: middledoi
Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS)
Genetics in Medicine 2019cited by 59position: lastdoi
Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions
Value in Health 2018cited by 79position: firstdoi
Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research
Genetics in Medicine 2017cited by 56position: firstdoi
Payer coverage policies for multigene tests
Nature Biotechnology 2017cited by 52position: firstdoi
Value of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online Sample
Medical Decision Making 2015cited by 14position: middledoi
The economic value of personalized medicine tests: what we know and what we need to know
Genetics in Medicine 2013cited by 116position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Michael P. Douglas · University of California, San Francisco7 papers (2013–2023)Deborah A. Marshall · Health Sciences Centre4 papers (2015–2021)Patricia A. Deverka · University of California, San Francisco3 papers (2017–2018)James Buchanan · University of Nottingham3 papers (2018–2021)Anne Slavotinek · Cincinnati Children's Hospital Medical Center2 papers (2019–2021)James D. Chambers · Tufts University1 papers (2017–2017)Heidi V. Russell · The University of Texas Health Science Center at Houston1 papers (2021–2021)Charles N. Rotimi · National Human Genome Research Institute1 papers (2021–2021) · 1 papers (2017–2017) · 1 papers (2021–2021)Bruce D. Gelb · New York Proton Center1 papers (2021–2021)Sheetal Kircher · Wake Forest University1 papers (2023–2023)Nanibaa’ A. Garrison · Oklahoma State University Center for Health Sciences1 papers (2021–2021) · 1 papers (2017–2017)Uri Ladabaum · Stanford Medicine1 papers (2015–2015)Stephanie Russo Carroll · University of Arizona1 papers (2021–2021)Ateesha F. Mohamed · University of Alabama at Birmingham1 papers (2015–2015)Dorothy E. Roberts · California University of Pennsylvania1 papers (2021–2021)Harold C. Sox · Humboldt-Universität zu Berlin1 papers (2017–2017)Beth Devine · Seattle University1 papers (2021–2021)